Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Hospital-Associated Multicenter Outbreak of Emerging Fungus Candida auris, Colombia, 2016.

Armstrong PA, Rivera SM, Escandon P, Caceres DH, Chow N, Stuckey MJ, Díaz J, Gomez A, Vélez N, Espinosa-Bode A, Salcedo S, Marin A, Berrio I, Varón C, Guzman A, Pérez-Franco JE, Escobar JD, Villalobos N, Correa JM, Litvintseva AP, Lockhart SR, Fagan R, Chiller TM, Jackson B, Pacheco O.

Emerg Infect Dis. 2019 Jul;25(7). doi: 10.3201/eid2507.180491.

2.

Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris.

Dudiuk C, Berrio I, Leonardelli F, Morales-Lopez S, Theill L, Macedo D, Yesid-Rodriguez J, Salcedo S, Marin A, Gamarra S, Garcia-Effron G.

J Antimicrob Chemother. 2019 May 12. pii: dkz178. doi: 10.1093/jac/dkz178. [Epub ahead of print]

PMID:
31081031
3.

Early-Onset Invasive Infection Due to Corynespora cassiicola Associated with Compound Heterozygous CARD9 Mutations in a Colombian Patient.

Arango-Franco CA, Moncada-Vélez M, Beltrán CP, Berrío I, Mogollón C, Restrepo A, Trujillo M, Osorio SD, Castro L, Gómez LV, Muñoz AM, Molina V, Del Río Cobaleda DY, Ruiz AC, Garcés C, Alzate JF, Cabarcas F, Orrego JC, Casanova JL, Bustamante J, Puel A, Arias AA, Franco JL.

J Clin Immunol. 2018 Oct;38(7):794-803. doi: 10.1007/s10875-018-0549-0. Epub 2018 Sep 28.

PMID:
30264381
4.

Limited ERG11 Mutations Identified in Isolates of Candida auris Directly Contribute to Reduced Azole Susceptibility.

Healey KR, Kordalewska M, Jiménez Ortigosa C, Singh A, Berrío I, Chowdhary A, Perlin DS.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01427-18. doi: 10.1128/AAC.01427-18. Print 2018 Oct.

5.

Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance.

Escandón P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, Rivera S, Misas E, Duarte C, Moulton-Meissner H, Welsh RM, Parra C, Pescador LA, Villalobos N, Salcedo S, Berrio I, Varón C, Espinosa-Bode A, Lockhart SR, Jackson BR, Litvintseva AP, Beltran M, Chiller TM.

Clin Infect Dis. 2019 Jan 1;68(1):15-21. doi: 10.1093/cid/ciy411.

PMID:
29788045
6.

Single-tube classical PCR for Candida auris and Candida haemulonii identification.

Theill L, Dudiuk C, Morales-Lopez S, Berrio I, Rodríguez JY, Marin A, Gamarra S, Garcia-Effron G.

Rev Iberoam Micol. 2018 Apr - Jun;35(2):110-112. doi: 10.1016/j.riam.2018.01.003. Epub 2018 Apr 21.

PMID:
29685376
7.

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.

Kordalewska M, Lee A, Park S, Berrio I, Chowdhary A, Zhao Y, Perlin DS.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00238-18. doi: 10.1128/AAC.00238-18. Print 2018 Jun.

8.

Comparative study of Candida spp. isolates: Identification and echinocandin susceptibility in isolates obtained from blood cultures in 15 hospitals in Medellín, Colombia.

Berrio I, Maldonado N, De Bedout C, Arango K, Cano LE, Valencia Y, Jiménez-Ortigosa C, Perlin DS, Gómez BL, Robledo C, Robledo J; Grupo GERMEN.

J Glob Antimicrob Resist. 2018 Jun;13:254-260. doi: 10.1016/j.jgar.2017.11.010. Epub 2017 Nov 26.

PMID:
29183771
9.

Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris.

Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS.

J Clin Microbiol. 2017 Aug;55(8):2445-2452. doi: 10.1128/JCM.00630-17. Epub 2017 May 24.

10.

Ertapenem resistance in 2 tertiary-care hospitals: Microbiology, epidemiology, and risk factors.

Maldonado N, Castro B, Berrio I, Manjarrés M, Robledo C, Robledo J.

Enferm Infecc Microbiol Clin. 2017 Oct;35(8):511-515. doi: 10.1016/j.eimc.2015.11.009. Epub 2016 Jan 6. English, Spanish.

PMID:
26778651

Supplemental Content

Loading ...
Support Center